Data Availability Statement The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. Supporting Information Filename Description jgh70805-sup-0001-SupplementaryFigure1.tifTIFF image, 3.1 MB Figure S1: Cumulative incidence of metachronous head and neck cancers after esophageal endoscopic resection according to exploratory risk stratification using baseline factors.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Ryu Ishihara
Enhanced visualization of fern-like surface architecture in a duodenal serrated lesion
Copyright: © 2026 Published by Elsevier Inc. on behalf of American Society for Gastrointestinal Endoscopy.
First-line tislelizumab plus chemotherapy versus placebo plus chemotherapy in unresectable advanced/metastatic esophageal squamous cell carcinoma: minimum 3-year survival follow-up of a randomized phase 3 trial (RATIONALE-306)
Abstract RATIONALE-306 previously demonstrated improved overall survival (OS) in participants treated with tislelizumab plus chemotherapy versus those receiving placebo plus chemotherapy as first-line treatment for advanced/metastatic esophageal squamous cell carcinoma, with a minimum follow-up of approximately 15 months. Exploratory long-term efficacy, safety, and quality of life (QoL) analyses after 36.0 months’ minimum follow-up are reported here.
Inverted Heterotopic Gastric Mucosa of the Duodenum Presenting as a Subepithelial Lesion
A 53-year-old man underwent screening esophagogastroduodenoscopy, which revealed a 20-mm subepithelial lesion (SEL) in the second portion of the duodenum. The patient was asymptomatic and had no relevant medical history. He was referred to our hospital for further evaluation. White-light endoscopy showed a sessile lesion covered with smooth non-neoplastic duodenal mucosa, with multiple depressed orifices over its surface (Figure 1a).
Long-term outcomes after endoscopic resection for cervical esophageal squamous cell carcinoma
Abbreviations BIS (bispectral index) CRT (chemoradiotherapy) CT (computed tomography) DSS (disease-specific survival) EMR (endoscopic mucosal resection) EP (epithelial) ER (endoscopic resection) ESCC (cervical esophageal squamous cell carcinoma) ESD (endoscopic submucosal dissection) FDG-PET/CT (18F fluorodeoxyglucose positron emission tomography/computed tomography) H&E (hematoxylin and eosin) HM (horizontal margins) HR (hazard ratio) IPTW (inverse probability of treatment weights) LPM...
Risk of Metastasis and Local Residual Cancer After Non‐Curative Endoscopic Submucosal Dissection for Esophageal Cancer
Endoscopic submucosal dissection (ESD) is widely used to treat early-stage esophageal squamous cell carcinoma (SCC). However, the risk of recurrence in non-curative cases remains uncertain. This study aimed to elucidate the risk of local and metastatic recurrence of esophageal SCC treated with ESD.
Artificial Intelligence in Gastrointestinal Endoscopy: The Japan Gastroenterological Endoscopy Society Position Statements
Conflicts of Interest Yuichi Mori (consultation: Olympus Europe; loyalty: Cybernet System), Haruhiko Ogata (lecture fee: Janssen Pharma, Olympus Medical, Takeda Pharmaceutical Co. Ltd.; scholarship donations: Kyorin Pharmaceutical, Mochida Pharmaceutical, AbbVie LLC, Mitsubishi Tanabe Pharma), Yutaka Saito (lecture fee: Olympus, EA Pharma, Olympus Marketing, Fuji Pharma, Erbe Elektromedizin GmbH; research funding: Olympus, Fujifilm), Kazuki Sumiyama (scholarship donation: Gadelius Medical;...
“Cold‐water” immersion endoscopic resection: Novel therapeutic technique for nonampullary duodenal lesions
BRIEF EXPLANATION Underwater conditions have recently been used during duodenal endoscopic treatment1; however, peristalsis remains a problem. Although antispasmodic medications can be administered, their effects are sometimes inefficient. Contraindications of butylscopolamine include glaucoma, arrhythmia, and prostatic hypertrophy, and glucagon is associated with the development of diabetes mellitus.
Salvage treatment after endoscopic submucosal dissection for a rectal neuroendocrine tumor: Premeditated peranal endoscopic myectomy
BRIEF EXPLANATION Endoscopic submucosal dissection (ESD) combined with dissection between the inner circular and outer longitudinal muscles of the lower rectum was first reported by Honjo et al.1 and subsequently reported as peranal endoscopic myectomy (PAEM) by Rahni et al.2 and Toyonaga et al.3 A 66-year-old man underwent ESD at another hospital for a neuroendocrine tumor in the lower rectum.
Esophageal rupture during endoscopic submucosal dissection closed using a novel suturing device
BRIEF EXPLANATION A 73-year-old man was diagnosed with metachronous esophageal cancer in the lower thoracic esophagus close to a postendoscopic submucosal dissection (ESD) scar (Fig. 1a). Mild stenosis in the middle thoracic esophagus, resulting from the post-ESD scar, was also noted (Fig. 1b). During ESD, the lateral parts of the lesion were carefully incised (Fig. 1c). However, the patient belched after the incision, revealing a rupture (Fig. 1d).
Multiple foci of dilated vessels as a new predictor of metachronous esophageal cancer
Original Article This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi:10.1111/den.14657.
Endoscopic Stenting for Malignant Dysphagia in Patients with Esophageal Cancer
Skip to main page content Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software Display options Abstract Malignant dysphagia is a common problem in patients with esophageal cancer.
Endoscopic Stenting for Malignant Dysphagia in Patients with Esophageal Cancer
This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessReview by Ryu Ishihara Department of Gastrointestinal Oncology, Osaka International Cancer Institute, 3-1-69, Otemae, Chuo-ku, Osaka 541-8567, Japan Curr. Oncol.
Usefulness of the ultrathin endoscope with a newly developed knife for complex esophageal endoscopic submucosal dissection
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Endoscopic Submucosal Dissection for Esophageal Cancer: Current and Future
1. Introduction Esophageal cancer is one of the most aggressive cancers, with a high mortality rate and poor prognosis. It is the seventh-most-common cancer and the sixth leading cause of cancer death globally, with 604,100 incidences and 544,076 deaths in 2020 [1]. Treatments for advanced esophageal cancer, including surgery and chemoradiotherapy, are invasive, and the prognosis is poor.
Predictors of stricture after non-circumferential endoscopic submucosal dissection of the esophagus and single-dose triamcinolone injection immediately after the procedure
Local triamcinolone (TA) injection is widely used to prevent stricture formation after endoscopic submucosal dissection (ESD). However, stricture develops in up to 45% of patients, despite this prophylactic measure. We therefore conducted a single-center prospective study to identify predictors of stricture after esophageal ESD and local TA injection.
Soft palate findings associated with a high risk of esophageal squamous cell carcinoma using an endoscopic system with enhanced depth-of-field imaging
Background and Aims We previously reported that 3 endoscopic findings of melanosis, whitish epithelium, and vasodilation in the soft palate are associated with a high risk of esophageal squamous cell carcinoma (ESCC). Conventional endoscopic systems require observation under magnification to evaluate vasodilation. This case series aims to present the evaluation of vasodilation without magnification using an endoscopic system with enhanced depth-of-field (EDOF) imaging.
Esophageal metal stent for malignant obstruction after prior radiotherapy
Abstract The association between severe adverse events (SAEs) and prior radiotherapy or stent type remains controversial. Patients with esophageal or esophagogastric junctional cancer who underwent stent placement (2005–2019) were enrolled in this retrospective study conducted at a tertiary cancer institute in Japan. The exclusion criteria were follow-up period of < 1 month and insufficient data on stent type or cancer characteristics.
Endoscopic resection of a squamous cell carcinoma on a pharyngeal flap
1 Inoue H. Takeshita K. Hori H. et al. Endoscopic mucosal resection with a cap-fitted panendoscope for esophagus, stomach, and colon mucosal lesions. Gastrointest Endosc. 1993; 39: 58-62 Endoscopic resection is a minimally invasive treatment for superficial pharyngeal cancer that requires general anesthesia and a laryngoscope to secure the operating space., , 3 Iizuka T. Kikuchi D. Hoteya S. et al.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Ryu
Contact Ryu, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack